Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Net Cash Flow (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Net Cash Flow for 15 consecutive years, with $688603.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Net Cash Flow rose 127.24% year-over-year to $688603.0, compared with a TTM value of $81852.0 through Mar 2025, up 100.9%, and an annual FY2025 reading of $81852.0, up 100.9% over the prior year.
  • Net Cash Flow was $688603.0 for Q1 2025 at Aethlon Medical, up from -$2.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $15.3 million in Q2 2021 and bottomed at -$3.3 million in Q1 2022.
  • Average Net Cash Flow over 5 years is -$386066.6, with a median of -$2.2 million recorded in 2022.
  • The sharpest move saw Net Cash Flow skyrocketed 340.52% in 2022, then plummeted 158.11% in 2023.
  • Year by year, Net Cash Flow stood at -$2.8 million in 2021, then rose by 24.56% to -$2.1 million in 2022, then decreased by 4.99% to -$2.2 million in 2023, then grew by 8.57% to -$2.0 million in 2024, then surged by 134.09% to $688603.0 in 2025.
  • Business Quant data shows Net Cash Flow for AEMD at $688603.0 in Q1 2025, -$2.0 million in Q4 2024, and -$2.2 million in Q3 2024.